Inovio Pharmaceuticals Inc.

Inovio, a leading DNA medicine biopharma, develops precision plasmid-based therapeutics for HPV, cancer, and infectious diseases. Its pipeline includes phase‑III VGX‑3100 and INO‑4800, and it partners with top pharma and global health agencies.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Hospitals and Health Care
Industry: Medical and Diagnostic Laboratories

Employees: 134
HQ: Plymouth Meeting

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
INO	Inovio Pharmaceuticals Inc. Cap: 0.1B	EQUITY	NMS	USD	US45773H2013	Active	📈